Skip to main content

Table 3 Patient wise number of cases who scored differently later by at least one grade of RNFS score at baseline

From: Evaluation of patients with multiple sclerosis using reverse nutech functional score and expanded disability status scale after human embryonic stem cell therapy

patient code

Number of affected parameters at BL (<BPG)

Alteration in score by at least one grade

No change; n (%)

Better; n (%)

80488

22

2 (9.1)

20 (90.9)

80499

12

3 (25.0)

9 (75.0)

80680

11

0

11 (100.0)

80710

15

3 (20.0)

12(80.0)

80723

12

3 (25.0)

9 (75.0)

80806

2

1 (50.0)

1 (50.0)

80926

4

2 (50.0)

2 (50.0)

81128

10

4 (40.0)

6 (60.0)

80562

17

0

17 (100.0)

80568

17

4 (23.5)

13 (76.5)

80626

14

4 (28.6)

10 (71.4)

80637

15

9 (60.0)

6 (40.0)

80673

10

5 (50.0)

5 (50.0)

80768

13

7 (53.8)

6 (46.2)

80889

8

3 (37.5)

5 (62.5)

80981

5

0

5 (100.0)

81105

12

6 (50.0)

6 (50.0)

81114

6

5 (83.3)

1 (16.7)

81180

17

10 (58.8)

7 (41.2)

81187

7

4 (57.1)

3 (42.9)

81238

4

0

4 (100.0)

81249

9

6 (66.7)

3 (33.3)

81275

9

8 (88.9)

1 (11.1)

81296

8

6 (75.0)

2 (25.0)

  1. RNFS reverse nutech functional score; BL baseline; BPG best possible grade